Uroplasty, Inc. (UPI) was a big mover last session, as the company saw its shares escalate over 28% on the day. This surge can be attributable to solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend of the company, as the stock shot up nearly 69% in the past one-month time frame. This sudden jump came on the back of robust third-quarter fiscal 2014 results.
In the last 30 days, though the company did not witness any estimate revision, the Zacks Consensus Estimate of a loss narrowed, suggesting that more solid trading could be ahead for Uroplasty. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Uroplasty currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the healthcare industry include Actelion Ltd. (ALIOF), Gentium S.p.A (GENT) and Affymetrix Inc. (AFFX). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
UROPLASTY INC (UPI): Free Stock Analysis Report
GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
AFFYMETRIX INC (AFFX): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading